[Mechanisms of development and characteristics of treatment of cardiac insufficiency in hypertension].
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D002301:Cardiac Glycosides / Q000627:therapeutic use; D002303:Cardiac Output, Low / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology; D004232:Diuretics / Q000627:therapeutic use; D006801:Humans; D006973:Hypertension / Q000150:complications*; D009200:Myocardial Contraction / Q000187:drug effects; D005996:Nitroglycerin / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D002301:Cardiac Glycosides; D004232:Diuretics; D014665:Vasodilator Agents; D005996:Nitroglycerin
Mekhanizmy razvitiia i osobennosti lecheniia serdechnoĭ nedostatochnosti pri gipertonicheskoĭ bolezni.